Deepak A. Kapoor, MD
A newly proposed urology-specific alternative payment model (APM) could save up to 37% on costs of care, partly by giving physicians incentives to pursue active surveillance (AS) rather than active intervention (AI), according to the Large Urology Group Practice Association (LUGPA).1
- Large Urology Group Practice Association. LUGPA advanced payment model for initial therapy of newly diagnosed patients with organ-confined prostate cancer. HHS website. https://aspe.hhs.gov/system/files/pdf/255906/LUGPAAPM.pdf. Published July 5, 2017. Accessed August 14, 2017.
- LUGPA submits first of its kind urology-specific APM [news release]. Schaumburgh, IL: Large Urology Group Practice Association; July 14, 2017. http://lugpa. org/press-release-lugpa-submits-first-of-its-kind-urology-specific-apm/. Accessed August 14, 2017.
- Physician-Focused Payment Model Technical Advisory Committee. Physicianfocused payment models: PTAC proposal submission instructions. HHS website. https://aspe.hhs.gov/system/files/pdf/255906/ProposalSubmissionInstructions.pdf. Updated August 4, 2017. Accessed August 21, 2017.
- American Urological Association. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. AUA website. http://www.auanet.org/guidelines/clinicallylocalized-prostate-cancer-new-(aua/astro/suo-guideline-2017). Published May 9, 2017. Accessed August 21, 2017.
... to read the full story